Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives
First Claim
Patent Images
1. A compound of formula (II):
- whereinG1 is CH2;
G2 is CH;
Rx is chloro, bromo, iodo, or O—
S(O)2CF3;
Rg is a C1-10 alkyl;
m is 0, or an integer having a value of 1, or 2;
R3 is a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-10 alkyl, aryl, arylC1-10 alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic or a heterocyclylC1-10 alkyl moiety, and wherein each of these moieties may be optionally substituted.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to a novel method of preparing of 2,4,8-trisubstituted pyrido[2,3-d]pyrimidin-7-one pharmacophores of Formula (II) or (IIa)
wherein
- G1 is CH2;
- G2 is CH;
- Rx is chloro, bromo, iodo, or O—S(O)2CF3;
- Rg is a C1-10 alkyl;
- m is 0, or an integer having a value of 1, or 2;
- R3 is a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-10 alkyl, aryl, arylC1-10 alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic or a heterocyclylC1-10 alkyl moiety, and wherein each of these moieties may be optionally substituted.
- which comprises reacting a compound of the formula:
wherein
- Ry is chloro, bromo, iodo, O—S(O)2CF3; and
- Rg is a C1-10 alkyl;
with a olefin forming reagent in a suitable base to yield a compound of Formula (II), or (IIa) wherein m=0 and oxidizing the sulphur as necessary or desired.
-
Citations
69 Claims
-
1. A compound of formula (II):
-
wherein G1 is CH2; G2 is CH; Rx is chloro, bromo, iodo, or O—
S(O)2CF3;Rg is a C1-10 alkyl; m is 0, or an integer having a value of 1, or 2; R3 is a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-10 alkyl, aryl, arylC1-10 alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic or a heterocyclylC1-10 alkyl moiety, and wherein each of these moieties may be optionally substituted. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52)
4-Chloro-8-(4-trifluoromethyl-phenyl)-2-methylsulfanyl-8H-pyrido[2,3-d]pyrimidin-7-one; 4-Chloro-8-(4-trifluoromethyl-phenyl)-2-methylsulfinyl-8H-pyrido[2,3-d]pyrimidin-7-one; 4-Chloro-8-(2,4-difluoro-phenyl)-2-methylsulfanyl-8H-pyrido[2,3-d]pyrimidin-7-one; 4-Chloro-8-(2,4-difluoro-phenyl)-2-methylsulfinyl-8H-pyrido[2,3-d]pyrimidin-7-one; 4-Chloro-8-(2,6-difluoro-phenyl)-2-methylsulfanyl-8H-pyrido[2,3-d]pyrimidin-7-one; and 4-Chloro-8-(2,6-difluoro-phenyl)-2-methylsulfinyl-8H-pyrido[2,3-d]pyrimidin-7-one.
-
-
41. The compound according to claim 2 wherein R9 is methyl.
-
42. The compound according to claim 3 wherein R9 is methyl.
-
43. The compound according to claim 41 wherein m is 0.
-
44. The compound according to claim 42 wherein m is 0.
-
45. The compound according to claim 41 wherein m is 2.
-
46. The compound according to claim 42 wherein m is 2.
-
47. The compound according claim 43 wherein Rx is chloro.
-
48. The compound according claim 44 wherein Rx is chloro.
-
49. The compound according to claim 47 wherein R3 is phenyl or a phenyl substituted one or more times independently by fluorine, chlorine, or methyl.
-
50. The compound according to claim 49 wherein R3 is phenyl, 4-trifluoromethyl-phenyl, 2-fluorophenyl, 2,6-difluoro-phenyl, 2,4-difluoro-phenyl, 2-chlorophenyl, 2-methylphenyl, or 2,6-dimethylphenyl.
-
51. The compound according to claim 48 wherein R3 is phenyl or a phenyl substituted one or more times independently by fluorine, chlorine, or methyl.
-
52. The compound according to claim 51 wherein R3 is phenyl, 4-trifluoromethyl-phenyl, 2-fluorophenyl, 2,6-difluoro-phenyl, 2,4-difluoro-phenyl, 2-chlorophenyl, 2-methylphenyl, or 2,6-dimethylphenyl.
-
13. A compound of the formula:
-
wherein G1 is —
CH2;G2 is CH; Rx is chloro, bromo, iodo, or O—
S(O)2CF3;X is R2, OR2″
, S(O)mR2″
, (CH2)n′
N(R11)S(O)mR2′
, (CH2)n′
N(R11)C(O)R2′
, (CH2)nNR4R14, or (CH2)n′
N(R2′
)(R2″
), or N(R10′
)—
Rh—
NH—
C(═
N—
CN)NRqRq′
;X1 is N(R11), O, S(O)m, or CR10R20; Rh is selected from an optionally substituted C1-10 alkyl, —
CH2—
C(O)—
CH2—
, —
CH2CH2—
O—
CH2—
CH2—
, —
CH2—
C(O)N(R10′
)CH2—
CH2—
, —
CH2—
N(R10′
)C(O)CH2—
, —
CH2—
CH(OR10′
)—
CH2, —
CH2—
C(O)O—
CH2—
CH2—
, or —
CH2—
CH2—
O—
C(O)CH2—
;Rq and Rq′
are independently selected at each occurrence from hydrogen, C1-10 alkyl, C3-7cycloalkyl, C3-7cycloalkylC1-10alkyl, C5-7 cycloalkenyl, C5-7 cycloalkenyl-C1-10alkyl, aryl, arylC1-10 alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic, or a heterocyclylC1-10 alkyl moiety, wherein all of the moieties, excluding hydrogen, are optionally substituted, or Rq and Rq′
together with the nitrogen to which they are attached form a 5 to 7 membered optionally substituted ring, which ring may contain an additional heteroatom selected from oxygen, nitrogen or sulfur;R2 is hydrogen, C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylalkyl, aryl, arylC1-10-alkyl, heteroaryl, heteroarylC1-10-alkyl, heterocyclic, or a heterocyclylC1-10-alkyl moiety, and wherein each of these moieties, excluding hydrogen, may be optionally substituted;
or R2 is the moiety (CR10R20)q′
X1(CR10R20)qC(A1)(A2)(A3), or C(A1)(A2)(A3);R2′
is hydrogen, C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylalkyl, aryl, arylC1-10-alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic, or a heterocyclylC1-10 alkyl moiety, and wherein each of these moieties, excluding hydrogen, may be optionally substituted;R2″
is hydrogen, C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylalkyl, aryl, arylC1-10-alkyl, heteroaryl, heteroarylC1-10-alkyl, heterocyclic, or a heterocyclylC1-10-alkyl moiety, and wherein these moieties, excluding hydrogen, may be optionally substituted;
orwherein R2″
is the moiety (CR10R20)tX1(CR10R20)qC(A1)(A2)(A3);A1 is an optionally substituted C1-10 alkyl, heterocyclic, heterocyclic C1-10 alkyl, heteroaryl, heteroaryl C1-10 alkyl, aryl, or aryl C1-10 alkyl; A2 is an optionally substituted C1-10 alkyl, heterocyclic, heterocyclic C1-10 alkyl, heteroaryl, heteroaryl C1-10 alkyl, aryl, or aryl C1-10 alkyl; A3 is hydrogen or is an optionally substituted C1-10 alkyl; R3 is a C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-10 alkyl, aryl, arylC1-10 alkyl, heteroaryl, heteroarylC1-10 alkyl, heterocyclic or a heterocyclylC1-10 alkyl moiety, and wherein each of these moieties may be optionally substituted; R4 and R14 are each independently selected from hydrogen, C1-10 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylC1-4alkyl, aryl, aryl-C1-14 alkyl, heterocyclic, heterocyclic C1-4 alkyl, heteroaryl or a heteroaryl C1-4 alkyl moiety, and wherein each of these moieties, excluding hydrogen, may be optionally substituted;
or the R4 and R14 together with the nitrogen which they are attached form an optionally substituted heterocyclic ring of 4 to 7 members, which ring optionally contains an additional heteroatom selected from oxygen, sulfur or nitrogen;R10 and R20 are independently selected from hydrogen or C1-4alkyl; R10′
is independently selected at each occurrence from hydrogen or C1-4alkyl;R11 is independently selected from hydrogen or C1-4alkyl; n′
is independently selected at each occurrence from 0 or an integer having a value of 1 to 10;m is independently selected at each occurrence from 0 or an integer having a value of 1 or 2; q is 0 or an integer having a value of 1 to 10; q′
is 0, or an integer having a value of 1 to 6;
ort is an integer having a value of 2 to 6. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69)
2-(Hydroxy-hydroxymethyl-ethylamino)-4-Chloro-8-(4-trifluoromethyl-phenyl)-8H-pyrido[2,3-d]pyrimidin-7-one; 2-(Hydroxy-hydroxymethyl-ethylamino)-4-Chloro-8-(2,4-difluoro-phenyl)-8H-pyrido[2,3-d]pyrimidin-7-one; and 2-(Hydroxy-hydroxymethyl-ethylamino)-4-Chloro-8-(2,6-difluoro-phenyl)-8H-pyrido[2,3-d]pyrimidin-7-one.
-
-
40. The compound according to claim 13 which is:
-
4-Chloro-8-(2,6-difluorophenyl)-2-{[2-hydroxy-1-(hydroxymethyl)ethyl]-amino}pyrido[2,3-d]pyrimidin-7(8H)-one; 4-chloro-2-{[3-(diethylamino)propyl]amino}-8-(2,6-difluorophenyl)pyrido[2,3-d]pyrimidin-7(8H)-one; 4-chloro-8-(2,6-difluorophenyl)-2-(4-methyl-1,4′
-bipiperidin-1′
-yl)pyrido[2,3-d]pyrimidin-7(8H)-one.
-
-
53. The compound according to claim 14 wherein Rx is chloro.
-
54. The compound according to claim 15 wherein Rx is chloro.
-
55. The compound according to claim 54 wherein R3 is an optionally substituted aryl.
-
56. The compound according to claim 55 wherein R3 is optionally substituted independently, one or more times, independently at each occurrence by halogen, C1-10 alkyl, hydroxy, C1-10 alkoxy, cyano, nitro, amino, or halosubstituted C1-10 alkyl.
-
57. The compound according to claim 54 wherein R3 is phenyl, or phenyl substituted one or more times independently by fluorine, chlorine or methyl.
-
58. The compound according to claim 54 wherein R3 is phenyl, 4-trifluoromethyl-phenyl, 2-fluorophenyl, 2,6-difluoro-phenyl, 2,4-difluoro-phenyl, 2-chlorophenyl, 2-methylphenyl, or 2,6-dimethylphenyl.
-
59. The compound according to claim 33 wherein Rx is chloro.
-
60. The compound according to claim 59 which is Formula (III).
-
61. The compound according to claim 59 wherein R3 is a phenyl substituted one or more times independently by fluorine, chlorine or methyl.
-
62. The compound according to claim 61 wherein X is 2-(dimethylamino)ethylamino.
-
63. The compound according to claim 13 wherein X is R2.
-
64. The compound according to claim 63 wherein R2 is an optionally substituted heterocyclic selected from the group consisting of tetrahydropyrrole, tetrahydropyran, tetrahydrofuran, tetrahydrothiophene, aziridinyl, pyrrolinyl, pyrrolidinyl, 2-oxo-1-pyrrolidinyl, 3-oxo-1-pyrrolidinyl, 1,3-benzodioxol-5-yl, imidazolinyl, imidazolidinyl, indolinyl, pyrazolinyl, pyrazolidinyl, piperidinyl, piperazinyl, morpholino and thiomorpholino.
-
65. The compound according to claim 64 wherein R2 is an optionally substituted one or mores times independently by an optionally substituted heterocyclic, heterocyclic alkyl, aryl, arylalkyl, alkyl, (CR10R20)nNReRe′
- , or (CR10R20)nN(R10′
)C(Z)OR7; andwherein Re are Re′
are each independently selected at each occurrence from hydrogen, C1-4 alkyl, C3-7 cycloalkyl, C3-7 cycloalkylC1-4alkyl, aryl, aryl-C1-14 alkyl, heterocyclic, heterocyclic C1-4 alkyl, heteroaryl or a heteroaryl C1-4 alkyl moiety;
or Re and Re′
together with the nitrogen which they are attached form an optionally substituted heterocyclic ring of 4 to 7 members, which ring optionally contains an additional heteroatom selected from oxygen, sulfur or nitrogen; andwherein each of these moieties, excluding hydrogen, may be substituted 1 to 4 times, independently at each occurrence by halogen;
hydroxy;
hydroxy substituted C1-10alkyl;
C1-10 alkoxy;
halosubstituted C1-10 alkoxy;
amino, mono &
di-substituted C1-4 alkyl amino, S(O)mRf′
;
C(O)Rj;
C(O)ORj;
(CR10R20)nN(R10′
)C(Z)OR7;
(CR10R20)nN(R10′
)C(Z)NRdRd′
;
C(O)NR4′
R14′
;
NR4′
C(O) C1-10alkyl;
NR4′
C(O)aryl;
cyano;
nitro;
C1-10 alkyl;
C3-7cycloalkyl;
C3-7cycloalkyl C1-10 alkyl;
halosubstituted C1-10 alkyl;
aryl, aryl C1-4 alkyl, heterocyclic, heterocyclicC1-4 alkyl, heteroaryl, or heteroarylC1-4alkyl, and wherein these aryl, heterocyclic, and heteroaryl containing moieties may be optionally substituted one to two times independently at each occurrence by halogen, C1-4 alkyl, hydroxy, hydroxy substituted C1-4 alkyl, C1-10 alkoxy, S(O)malkyl, amino, mono &
di-substituted C1-4 alkyl amino, C1-4 alkyl, or CF3;Rd and Rd′
are each independently selected from hydrogen, C1-4 alkyl, C3-5 cycloalkyl, C3-5 cycloalkylC1-4alkyl, or the Rd and Rd′
together with the nitrogen which they are attached form an optionally substituted heterocyclic ring of 5 to 6 members, which ring optionally contains an additional heteroatom selected from oxygen, sulfur or NR9′
; andwherein the Rd and Rd′
moieties which are C1-4 alkyl, C3-6cycloalkyl, C3-6cycloalkylC1-4 alkyl, and the R4 and R14 cyclized ring are optionally substituted, 1 to 4 times, independently by halogen;
halosubstituted C1-4 alkyl;
hydroxy;
hydroxy substituted C1-4alkyl;
C1-4 alkoxy;
halosubstituted C1-4 alkoxy;
S(O)mRf, C(O)Rj;
C(O)O Rj;
C(O)NR4′
R14′
, NR4′
C(O)C1-4alkyl;
S(O)2NR4′
R14′
C1-4 alkyl;
NR4′
R14′
S(O)2C1-4 alkyl;
or NR4′
R14′
;Rf is independently selected at each occurrence from C1-10alkyl, aryl, aryl C1-10alkyl, heteroaryl, heteroaryl C1-10alkyl, heterocyclic, or a heterocyclic C1-10alkyl moiety, and wherein these moieties may all be optionally substituted; Rf′
is independently selected at each occurrence from hydrogen, C1-10alkyl, aryl, aryl C1-10alkyl, heteroaryl, heteroaryl C1-10alkyl, heterocyclic, heterocyclic C1-10alkyl, or NR4′
R14′
and wherein these moieties may all be optionally substituted;R4′
and R14′
are each independently selected at each occurrence from hydrogen or C1-4 alkyl, or R4′
and R14′
can cyclize together with the nitrogen to which they are attached to form a 5 to 7 membered ring which optionally contains an additional heteroatom selected from oxygen, sulfur or NR9′
;R9′
is independently selected at each occurrence from hydrogen, or C1-4 alkyl;Rj is independently selected at each occurrence from hydrogen, C1-4alkyl, aryl, aryl C1-4alkyl, heteroaryl, heteroaryl C1-4alkyl, heterocyclic, or a heterocyclic C1-4alkyl moiety, and wherein these moieties, excluding hydrogen, may be optionally substituted; and n is independently selected at each occurrence from 0 or an integer having a value of 1 to 10.
- , or (CR10R20)nN(R10′
-
66. The compound according to claim 65 wherein the R2 optionally substituted heterocyclic is selected from an optionally substituted morpholino, piperidine, or pyrrolidinyl.
-
67. The compound according to claim 64 wherein R2 is an optionally substituted piperidinyl or piperazinyl ring.
-
68. The compound according to claim 63 wherein R2 is a 4-amino-1-piperidinyl, 1,1-dimethylethyl)oxy]-carbonyl}amino)-1-piperidinyl, 4-methyl-1-piperazinyl, 4-ethyl-1-piperazinyl, 4-propyl-1-piperazinyl, 4-butyl-1-piperazinyl, 4-(methylamino)-1-piperidinyl, 1,1-dimethylethyl-4-piperidinyl}methylcarbamate, 4-phenyl-1-piperazinyl, 1,4′
- -bipiperidin-1′
-yl, 4-(1-pyrrolidinyl)-1-piperidinyl, 4-methyl-1,4′
-bipiperidin-1′
-yl, 4-(4-morpholinyl)-1-piperidinyl, 4-(diphenylmethyl)-1-piperazinyl, or 4-methylhexahydro-1H-1,4-diazepin-1-yl.
- -bipiperidin-1′
-
69. The compound according to claim 68 wherein R2 is 4-methyl-1,4′
- -bipiperidin-1′
-yl, or (1-pyrrolidinyl)-1-piperidinyl.
- -bipiperidin-1′
Specification